IL82645A0 - Pharmaceutical compositions containing polypeptides - Google Patents

Pharmaceutical compositions containing polypeptides

Info

Publication number: IL82645A0
Authority: IL; Israel
Prior art keywords: pharmaceutical compositions; compositions containing; containing polypeptides; polypeptides; pharmaceutical
Prior art date: 1986-05-27

Application number

IL82645A

Other languages

English (en)

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-05-27

Filing date

1987-05-25

Publication date

1987-11-30

1986-05-27 Priority claimed from CH2138/86A external-priority patent/CH667994A5/de

1987-05-25 Application filed by Sandoz Ag filed Critical Sandoz Ag

1987-11-30 Publication of IL82645A0 publication Critical patent/IL82645A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

IL82645A 1986-05-27 1987-05-25 Pharmaceutical compositions containing polypeptides IL82645A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH214486		1986-05-27
CH2138/86A CH667994A5 (de)	1986-05-27	1986-05-27	Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen.

Publications (1)

Publication Number	Publication Date
IL82645A0 true IL82645A0 (en)	1987-11-30

Family

ID=25689611

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL82645A IL82645A0 (en)	1986-05-27	1987-05-25	Pharmaceutical compositions containing polypeptides

Country Status (21)

Country	Link
US (1)	US5393738A (de)
KR (1)	KR870010870A (de)
AU (1)	AU601740B2 (de)
BE (1)	BE1000722A4 (de)
CA (1)	CA1299495C (de)
DE (1)	DE3716437A1 (de)
DK (1)	DK265587A (de)
ES (1)	ES2008126A6 (de)
FI (1)	FI872313A (de)
FR (2)	FR2599254B1 (de)
GB (1)	GB2190838B (de)
GR (1)	GR870820B (de)
HU (1)	HU198626B (de)
IL (1)	IL82645A0 (de)
LU (1)	LU86901A1 (de)
MY (1)	MY101233A (de)
NL (1)	NL8701143A (de)
NO (1)	NO171484C (de)
NZ (1)	NZ220418A (de)
SE (1)	SE8702188L (de)
WO (1)	WO1987007149A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3822557C2 (de) *	1987-07-10	1998-07-02	Ciba Geigy Ag	Arzneimittel, enthaltend Somatostatine
FR2668933B1 (fr) *	1990-06-15	1995-05-05	Sandoz Sa	Composition pharmaceutique a base de somatostatine.
GB9013448D0 (en) *	1990-06-15	1990-08-08	Sandoz Ltd	Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
US5571788A (en) *	1991-12-09	1996-11-05	Ciba-Geigy Corporation	Stable calcitonin pharmaceutical compositions
DE19949897A1 (de) *	1999-10-15	2001-04-19	Rainer Rogasch	Formkörper und Verfahren zu dessen Herstellung
EP1118333A1 (de) *	2000-01-18	2001-07-25	Eurand International S.P.A.	Zusammensetzungen mit erhöhter oraler Bioverfügbarkeit
EP1787658B1 (de)	2005-11-10	2012-03-14	CHEMI S.p.A.	Formulierungen mit verzögerter Freisetzung, die Somatostatin-analoge Wachstumshormoninhibitoren enthalten
WO2010032140A2 (en) *	2008-09-17	2010-03-25	Chiasma Inc.	Pharmaceutical compositions and related methods of delivery
AU2015201581B2 (en) *	2008-09-17	2017-03-09	Amryt Endo, Inc.	Pharmaceutical Compositions and Related Methods of Delivery
US20110142889A1 (en) *	2009-12-16	2011-06-16	Nod Pharmaceuticals, Inc.	Compositions and methods for oral drug delivery
EP2512454A2 (de)	2009-12-16	2012-10-24	Nod Pharmaceuticals, Inc.	Zusammensetzungen und verfahren zur wirkstofffreisetzung
US20110182985A1 (en) *	2010-01-28	2011-07-28	Coughlan David C	Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
AU2015360485B2 (en)	2014-12-10	2020-06-25	Amryt Endo, Inc.	Oral octreotide administered in combination with other therapeutic agents
US10265384B2 (en)	2015-01-29	2019-04-23	Novo Nordisk A/S	Tablets comprising GLP-1 agonist and enteric coating
EP3253401A4 (de)	2015-02-03	2018-11-21	Chiasma Inc.	Verfahren zur behandlung von krankheiten
US11141457B1 (en)	2020-12-28	2021-10-12	Amryt Endo, Inc.	Oral octreotide therapy and contraceptive methods

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1062898A (en) *	1912-12-09	1913-05-27	Fred Drew	Automobile.
GB1062898A (en) *	1963-06-14	1967-03-22	Evans Medical Ltd	Pharmaceutical compositions containing protamines
CA959759A (en) *	1970-01-15	1974-12-24	John J. Miskel	Method for absorption of drugs
NL167323C (nl) *	1970-09-26	1981-12-16	Organon Nv	Werkwijze ter bereiding van een psychofarmacologisch preparaat.
US4179337A (en) *	1973-07-20	1979-12-18	Davis Frank F	Non-immunogenic polypeptides
US4041155A (en) *	1974-10-29	1977-08-09	American Home Products Corporation	Long acting somatostatin composition
US4151276A (en) *	1975-05-12	1979-04-24	Armour Pharmaceutical Company	Method of suppressing gastric acid secretion by the oral administration of calcitonin
CA1098444A (en) *	1975-05-26	1981-03-31	Leo Geller	Peptide preparations with prolonged action
NL7607987A (nl) *	1975-08-08	1977-02-10	Merck & Co Inc	Werkwijze voor het bereiden van peptiden.
SE7612534L (sv) *	1975-12-01	1977-06-02	Henkel & Cie Gmbh	Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
US4087390A (en) *	1977-02-02	1978-05-02	Eli Lilly And Company	Somatostatin analogs and intermediates thereto
US4093574A (en) *	1977-02-02	1978-06-06	Eli Lilly And Company	Somatostatin analogs and intermediates thereto
DK144731C (da) *	1976-07-30	1982-10-18	Nordisk Insulinlab	Fremgangsmaade til isolering af proteinhormoner stammende fra humant hypofysevaev
US4230695A (en) *	1976-08-02	1980-10-28	Vitose Corporation	Enhanced protein assimilation with fructose
JPS5920647B2 (ja) *	1976-10-01	1984-05-15	武田薬品工業株式会社	注射剤
US4162248A (en) *	1976-10-14	1979-07-24	Merck & Co., Inc.	Somatostatin analogs
GB2008403B (en) *	1977-11-04	1982-07-28	Christie R B Parsons J A	Pharmaceutical compositions
CA1107273A (en) *	1978-05-19	1981-08-18	Chester A. Meyers	Somatostatin analogs having a substituted tryptophyl residue in position eight
CY1327A (en) *	1979-11-27	1986-06-27	Sandoz Ag	Novel polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use
JPS56122309A (en) *	1980-03-03	1981-09-25	Teijin Ltd	Calcitonin pharmaceutical for rectal administration
JPS5885813A (ja) *	1981-11-17	1983-05-23	Toyo Jozo Co Ltd	吸収性良好な製剤
JPS57146723A (en) *	1981-03-06	1982-09-10	Toyo Jozo Co Ltd	Pharmaceutical preparation having improved absorption
JPS57146722A (en) *	1981-03-06	1982-09-10	Toyo Jozo Co Ltd	Pharmaceutical preparation having improved absorption
JPS57118509A (en) *	1981-01-14	1982-07-23	Toyo Jozo Co Ltd	Novel preparation of high absorbability
US4900730A (en) *	1981-01-14	1990-02-13	Toyo Jozo Co., Ltd.	Preparation which promotes the absorption of peptides
GB2092002B (en) *	1981-01-14	1985-09-11	Toyo Jozo Kk	Suppositories injectable solutions
JPS57128634A (en) *	1981-02-03	1982-08-10	Eisai Co Ltd	Elastase-containing compound increasing absorption
EP0077354A4 (de) *	1981-04-27	1983-09-30	Baxter Travenol Lab	Dialyselösung glukose, aminosäuren und insulin enthaltend.
EP0083619A1 (de) *	1981-07-17	1983-07-20	Nordisk Insulinlaboratorium	Stabile wässrige arzneimittel-isulin-zusammensetzung und verfahren zu deren herstellung
US4457916A (en) *	1982-08-31	1984-07-03	Asahi Kasei Kogyo Kabushiki Kaisha	Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
GB2127689B (en) *	1982-10-05	1986-07-09	Sandoz Ltd	Calcitonin inhalation compositions
US4452775A (en) *	1982-12-03	1984-06-05	Syntex (U.S.A.) Inc.	Cholesterol matrix delivery system for sustained release of macromolecules
JPS59163313A (ja) *	1983-03-09	1984-09-14	Teijin Ltd	経鼻投与用ペプチドホルモン類組成物
EP0164397B1 (de) *	1983-11-21	1990-07-04	The Regents Of The University Of Minnesota	Gepuffertes polyol-hormones gemisch zur verwendung bei chronischer parenteraler hormonverabreichung
JPS6197229A (ja) *	1984-10-18	1986-05-15	Chugai Pharmaceut Co Ltd	安定なエリトロポエチン製剤
JPS61267528A (ja) *	1984-11-26	1986-11-27	Yamanouchi Pharmaceut Co Ltd	吸収促進剤を含有するカルシトニン経鼻剤
US4650787A (en) *	1985-04-25	1987-03-17	Schally Andrew Victor	Biologically active octapeptides

1987
- 1987-05-13 HU HU872150A patent/HU198626B/hu not_active IP Right Cessation
- 1987-05-13 NL NL8701143A patent/NL8701143A/nl not_active Application Discontinuation
- 1987-05-16 DE DE19873716437 patent/DE3716437A1/de not_active Ceased
- 1987-05-22 GB GB8712193A patent/GB2190838B/en not_active Expired - Lifetime
- 1987-05-22 WO PCT/CH1987/000056 patent/WO1987007149A1/de unknown
- 1987-05-25 DK DK265587A patent/DK265587A/da not_active Application Discontinuation
- 1987-05-25 GR GR870820A patent/GR870820B/el unknown
- 1987-05-25 FR FR878707368A patent/FR2599254B1/fr not_active Expired
- 1987-05-25 SE SE8702188A patent/SE8702188L/ not_active Application Discontinuation
- 1987-05-25 IL IL82645A patent/IL82645A0/xx not_active IP Right Cessation
- 1987-05-25 NZ NZ220418A patent/NZ220418A/xx unknown
- 1987-05-25 MY MYPI87000714A patent/MY101233A/en unknown
- 1987-05-25 AU AU73364/87A patent/AU601740B2/en not_active Ceased
- 1987-05-25 CA CA000537928A patent/CA1299495C/en not_active Expired - Lifetime
- 1987-05-25 BE BE8700598A patent/BE1000722A4/fr not_active IP Right Cessation
- 1987-05-25 FI FI872313A patent/FI872313A/fi not_active Application Discontinuation
- 1987-05-25 NO NO872174A patent/NO171484C/no unknown
- 1987-05-26 LU LU86901A patent/LU86901A1/fr unknown
- 1987-05-26 KR KR870005303A patent/KR870010870A/ko not_active Application Discontinuation
- 1987-05-27 ES ES8701555A patent/ES2008126A6/es not_active Expired
1989
- 1989-06-14 FR FR8907995A patent/FR2630916B1/fr not_active Expired - Fee Related
1993
- 1993-01-25 US US08/008,383 patent/US5393738A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HU198626B (en)	1989-11-28
FI872313A (fi)	1987-11-28
FR2630916B1 (fr)	1993-10-22
FR2599254A1 (fr)	1987-12-04
KR870010870A (ko)	1987-12-18
GR870820B (en)	1987-09-25
HUT43956A (en)	1988-01-28
CA1299495C (en)	1992-04-28
WO1987007149A1 (en)	1987-12-03
FR2630916A1 (fr)	1989-11-10
US5393738A (en)	1995-02-28
ES2008126A6 (es)	1989-07-16
AU7336487A (en)	1987-12-03
DE3716437A1 (de)	1987-12-03
MY101233A (en)	1991-08-17
GB2190838B (en)	1990-12-12
GB8712193D0 (en)	1987-06-24
NO171484B (no)	1992-12-14
DK265587D0 (da)	1987-05-25
NO872174D0 (no)	1987-05-25
FR2599254B1 (fr)	1989-12-01
AU601740B2 (en)	1990-09-20
DK265587A (da)	1987-11-28
NZ220418A (en)	1990-07-26
SE8702188D0 (sv)	1987-05-25
NL8701143A (nl)	1987-12-16
SE8702188L (sv)	1987-11-28
NO872174L (no)	1987-11-30
BE1000722A4 (fr)	1989-03-21
LU86901A1 (fr)	1987-12-16
GB2190838A (en)	1987-12-02
NO171484C (no)	1993-03-24
FI872313A0 (fi)	1987-05-25

Publication	Publication Date	Title
GB2196964B (en)	1990-07-18	Pharmaceutical compositions
GB8716301D0 (en)	1987-08-19	Pharmaceutical compositions
GB8717582D0 (en)	1987-09-03	Pharmaceutical compositions
GB8723121D0 (en)	1987-11-04	Pharmaceutical compositions
GB8714625D0 (en)	1987-07-29	Pharmaceutical compositions
ZA872520B (en)	1987-11-25	Pharmaceutical compositions
GB8717581D0 (en)	1987-09-03	Pharmaceutical compositions
GB8618259D0 (en)	1986-09-03	Pharmaceutical compositions
GB2191696B (en)	1991-01-16	Pharmaceutical compositions
IL82645A0 (en)	1987-11-30	Pharmaceutical compositions containing polypeptides
GB8728957D0 (en)	1988-01-27	Pharmaceutical compositions
GB8723120D0 (en)	1987-11-04	Pharmaceutical compositions
GB8723118D0 (en)	1987-11-04	Pharmaceutical compositions
GB2188235B (en)	1990-11-14	Pharmaceutical compositions
GR871999B (en)	1988-04-26	Pharmaceutical compositions
GB8719387D0 (en)	1987-09-23	Pharmaceutical compositions
GB8621756D0 (en)	1986-10-15	Pharmaceutical compositions
GB8615041D0 (en)	1986-07-23	Pharmaceutical compositions
GB8623587D0 (en)	1986-11-05	Pharmaceutical compositions
ZA871721B (en)	1987-08-31	Pharmaceutical compositions
GB8621085D0 (en)	1986-10-08	Pharmaceutical compositions
GB8623588D0 (en)	1986-11-05	Pharmaceutical compositions
GB8630932D0 (en)	1987-02-04	Pharmaceutical compositions
GB8616695D0 (en)	1986-08-13	Pharmaceutical compositions
GB8616397D0 (en)	1986-08-13	Pharmaceutical compositions

Legal Events

Date	Code	Title	Description
1998-04-05	RH	Patent void